Subscribe: EurekAlert! - Cancer
http://www.eurekalert.org/rss/cancer.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
cancer  cancers  cell  dna  institute  million  new  patient centered  patients  research  risk  scientists  tumor  university  women 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: EurekAlert! - Cancer

EurekAlert! - Cancer Research News



The premier online source for science news since 1996. A service of the American Association for the Advancement of Science.



Last Build Date: Thu, 17 Aug 2017 10:54:01 EDT

Copyright: Copyright 2017 American Association for the Advancement of Science (AAAS); All rights reserved.
 



Wistar scientists develop novel immunotherapy technology for prostate cancer

Thu, 17 Aug 2017 00:00:00 EDT

(The Wistar Institute) A study led by Wistar scientists describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer-specific protein.



NASA protects its super heroes from space weather

Thu, 17 Aug 2017 00:00:00 EDT

(NASA/Johnson Space Center) When astronauts travel in space they can't see or even feel radiation. However, NASA's Human Research Program (HRP) is studying the effects radiation plays on the human body and developing ways to monitor and protect against this silent hazard.



Smoking linked to frailty in older adults

Thu, 17 Aug 2017 00:00:00 EDT

(Oxford University Press USA) A recent paper published in Age & Ageing, the scientific journal of the British Geriatrics Society, finds that current smoking in older people increases the risk of developing frailty, though former smokers did not appear to be at higher risk.



Outdoor light at night linked with increased breast cancer risk in women

Thu, 17 Aug 2017 00:00:00 EDT

(Harvard T.H. Chan School of Public Health) Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School of Public Health. The link was stronger among women who worked night shifts.



New terahertz imaging approach could speed up skin cancer detection

Thu, 17 Aug 2017 00:00:00 EDT

(The Optical Society) Researchers have developed a new terahertz imaging approach that, for the first time, can acquire micron-scale resolution images while retaining computational approaches designed to speed up image acquisition.



Energy dense foods may increase cancer risk regardless of obesity status

Thu, 17 Aug 2017 00:00:00 EDT

(Elsevier) While there is a proven link between obesity and certain types of cancer, less is known about how the ratio of energy to food weight, otherwise known as dietary energy density (DED), contributes to cancer risk. To find out, researchers looked at DED in the diets of post-menopausal women and discovered that consuming high DED foods was tied to a 10 percent increase in obesity-related cancer among normal weight women.



New strategy to treat aggressive lung cancer

Wed, 16 Aug 2017 00:00:00 EDT

(St. Joseph's Hospital and Medical Center) Research conducted by a team of Norton Thoracic Institute scientists on a novel therapeutic avenue for an aggressive and difficult to treat subgroup of lung cancer was published in the Aug. 15, 2017 issue of Cancer Research.



Blood biopsy reveals unique, targetable genetic alterations in patients with rare cancer

Wed, 16 Aug 2017 00:00:00 EDT

(University of California - San Diego) Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.



Specialists make breakthrough in the treatment of anal cancer

Wed, 16 Aug 2017 00:00:00 EDT

(University of Manchester) Specialists at The Christie and The University of Manchester have made a breakthrough which could potentially improve detection and treatment of anal cancer, as well as have wider implications for other cancers.



Researchers identify estrogen receptor stem cells in the in the mammary gland

Wed, 16 Aug 2017 00:00:00 EDT

(Université libre de Bruxelles) One of the key questions in stem cell and cancer biology is to understand the cellular hierarchy governing tissue development and maintenance and the cancer cell of origin. In a study published in Cell Reports, researchers lead by Cédric Blanpain identified a novel lineage-restricted stem cell in the mammary gland. In the future, this model will be used to assess whether the clinical heterogeneity observed in breast cancers arises from their different cancer cell of origin.



Researchers map brain tumor cells' adaptation to oxygen deprivation

Wed, 16 Aug 2017 00:00:00 EDT

(Lund University) The most aggressive variant of brain tumor -- glioblastoma -- has an average survival rate of 15 months. There is therefore an urgent need for new treatment strategies for this group of patients. A research team from Lund University in Sweden has now identified new factors which may affect the tumor cells' ability to resist treatment. The study has been published in Cell Reports.



Insilico establishes collaboration with GSK to discover novel biological targets and molecules

Wed, 16 Aug 2017 00:00:00 EDT

(InSilico Medicine, Inc.) Insilico Medicine has formed a collaboration with GSK to to explore how Insilico's AI capability can enhance its drug discovery process. The collaboration has been established following the successful completion by Insilico of a series of pilot challenges. As a first stage of the collaboration, GSK will evaluate Insilico's technology in the identification of novel biological targets and pathways of interest to GSK.



Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

Wed, 16 Aug 2017 00:00:00 EDT

(Dana-Farber Cancer Institute) Study explains why CDK4/6 inhibitors can shrink tumor in some advanced breast cancers . CDK4/6 inhibitors trigger the immune system to attack tumor cells. CDK4/6 inhibitors can also enhance anti-cancer effect of immunotherapy agents.



Toxic formaldehyde is produced inside our own cells, scientists discover

Wed, 16 Aug 2017 00:00:00 EDT

(Medical Research Council) New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment -- it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing cancer therapies, according to research led by scientists from the Medical Research Council Laboratory of Molecular Biology.



Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

Wed, 16 Aug 2017 00:00:00 EDT

(Johns Hopkins Medicine) In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers.



Popular immunotherapy target turns out to have a surprising buddy

Wed, 16 Aug 2017 00:00:00 EDT

(Netherlands Cancer Institute) The majority of current cancer immunotherapies focus on PD-L1. This well-studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. Researchers from the Netherlands Cancer Institute publish these findings in the leading journal Nature on Aug. 16.



For post-menopausal women, vaginal estrogens do not raise risk of cancer, other diseases

Wed, 16 Aug 2017 00:00:00 EDT

(University of California - Los Angeles Health Sciences) Women who have gone through menopause and who have been using a vaginal form of estrogen therapy do not have a higher risk of cardiovascular disease and cancer than women who have not been using any type of estrogen.



Noninvasive detection for early stage cancers from circulating DNA

Wed, 16 Aug 2017 00:00:00 EDT

(American Association for the Advancement of Science) A new DNA sequencing-based method could help noninvasively detect early stage cancers by analyzing fragments of genetic material circulating in the blood that originate from tumors.



Impaired DNA replication can cause epigenetic changes inherited for several generations

Wed, 16 Aug 2017 00:00:00 EDT

(Center for Genomic Regulation) Scientists reveal that a fault in the process that copies DNA during cell division can cause epigenetic changes that may be inherited for up-to five generations. They also identified the cause of these epigenetic changes, which is related to the loss of a molecular mechanism in charge of silencing genes.



Chapman University's School of Pharmacy receives research grants totaling $3.5 million

Tue, 15 Aug 2017 00:00:00 EDT

(Chapman University) Chapman University's four-year-old School of Pharmacy continues its aggressive growth in federal grant awards. The School's faculty -- in addition to the grant money some have brought with them from other institutions -- have actively submitted proposals for research funding each year, bringing the total awards since the School opened in 2014 to just more than $3.5 million through nearly 30 awards.



PCORI Board approves nearly $74 million for research on palliative care

Tue, 15 Aug 2017 00:00:00 EDT

(Patient-Centered Outcomes Research Institute) The Patient-Centered Outcomes Research Institute's (PCORI) Board of Governors today approved nearly $74 million to fund seven studies comparing the effectiveness of different strategies for delivering palliative care. These projects will focus on advanced care planning for patients with serious illnesses and examine which approaches to delivering palliative care to patients in the community work best to improve quality of care and quality of life.



CHLA researcher awarded $1.9 million by NIH

Tue, 15 Aug 2017 00:00:00 EDT

(Children's Hospital Los Angeles) Muller Fabbri, MD, PhD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, has been awarded $1.9 million by the National Cancer Institute of the NIH to further his research on neuroblastoma. The research will focus on a completely new strategy targeting immune cells that contribute to disease progression with a goal toward the development of more potent immunotherapies to improve the outcomes for children with this disease.



PCORI Board approves $115 million to support 20 new patient-centered CER research studies

Tue, 15 Aug 2017 00:00:00 EDT

(Patient-Centered Outcomes Research Institute) The Patient-Centered Outcomes Research Institute's (PCORI) Board of Governors today approved more than $115 million to fund 20 comparative clinical effectiveness research (CER) studies on a range of conditions that impose high burdens on patients, their families and the healthcare system. The Board also approved $4 million to support four projects focused on improving methods for conducting CER.



A metabolic treatment for pancreatic cancer?

Tue, 15 Aug 2017 00:00:00 EDT

(Boston Children's Hospital) Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent.



Liquid biopsies find distinct genomic profiles in most patients with carcinoma of unknown primary

Tue, 15 Aug 2017 00:00:00 EDT

(American Association for Cancer Research) Next-generation sequencing of circulating tumor DNA identified distinct genomic profiles with potentially targetable alterations in 99.7 percent of patients with carcinoma of unknown primary who have detectable alterations.